Gene Therapy to Prevent Organophosphate Intoxication
- 1 May 2001
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 173 (1), 1-6
- https://doi.org/10.1006/taap.2001.9169
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart diseaseAtherosclerosis, 2000
- Low Paraoxonase in Persian Gulf War Veterans Self-Reporting Gulf War SyndromeBiochemical and Biophysical Research Communications, 2000
- Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseasesAtherosclerosis, 2000
- Association of Low PON1 Type Q (Type A) Arylesterase Activity with Neurologic Symptom Complexes in Gulf War VeteransToxicology and Applied Pharmacology, 1999
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- Paraoxonase protects against chlorpyrifos toxicity in miceToxicology Letters, 1995
- Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in ratsToxicology and Applied Pharmacology, 1990
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961